Patents by Inventor John McMichael

John McMichael has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20020123041
    Abstract: The present invention relates to a treatment for animals having canine distemper by administering a composition comprising an attenuated canine distemper virus a sub-vaccine virus level effective to alleviate symptoms canine distemper. The invention also provides a treatment for animals having canine distemper by administering a composition comprising an attenuated canine measles virus a sub-vaccine virus level effective to alleviate symptoms canine distemper.
    Type: Application
    Filed: April 30, 2002
    Publication date: September 5, 2002
    Inventor: John McMichael
  • Publication number: 20020115632
    Abstract: Methods for treating symptoms of asthma, allergies and otitis media in a patient, are presented. Methods comprise administering an effective amount of DNA to a subject in a manner so as not to effect gene transfer.
    Type: Application
    Filed: April 1, 2002
    Publication date: August 22, 2002
    Applicant: Milkhaus Laboratory, Inc.
    Inventor: John McMichael
  • Patent number: 6437093
    Abstract: A method for treatment of symptoms of a respiratory disease or pain in a subject comprising administering to said subject a Substance P in an amount effective to alleviate those symptoms.
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: August 20, 2002
    Assignee: Milkhaus Laboratory, Inc.
    Inventors: Allan D. Lieberman, John McMichael
  • Patent number: 6436401
    Abstract: The invention provides methods and compositions for alleviating the symptoms of diabetes with a pharmaceutical composition including a combination of anti-glutamic acid decarboxylase (anti-GAD) and anti-insulin antibodies.
    Type: Grant
    Filed: July 30, 2001
    Date of Patent: August 20, 2002
    Assignee: Milkhaus Laboratory, Inc.
    Inventor: John McMichael
  • Publication number: 20020081300
    Abstract: The invention provides methods and compositions for alleviating the symptoms of diabetes with a pharmaceutical composition including a combination of anti-glutamic acid decarboxylase (anti-GAD) and anti-insulin antibodies.
    Type: Application
    Filed: July 30, 2001
    Publication date: June 27, 2002
    Inventor: John McMichael
  • Patent number: 6383741
    Abstract: The present invention relates to a treatment for animals having canine distemper by administering a composition comprising an attenuated canine distemper virus a sub-vaccine virus level effective to alleviate symptoms canine distemper. The invention also provides a treatment for animals having canine distemper by administering a composition comprising an attenuated canine measles virus a sub-vaccine virus level effective to alleviate symptoms canine distemper.
    Type: Grant
    Filed: December 22, 2000
    Date of Patent: May 7, 2002
    Assignee: Milkhaus Laboratory, Inc.
    Inventor: John McMichael
  • Publication number: 20020012667
    Abstract: The present invention provides a method of preventing allograft rejection in a transplant recipient comprising the step of administering to the recipient an antigenic preparation presenting antigens characteristic of the allograft in an amount effective to neutralize the immune response to the allograft.
    Type: Application
    Filed: April 13, 2001
    Publication date: January 31, 2002
    Inventor: John McMichael
  • Publication number: 20010031267
    Abstract: The present invention relates to a treatment for animals having canine distemper by administering a composition comprising an attenuated canine distemper virus a sub-vaccine virus level effective to alleviate symptoms canine distemper. The invention also provides a treatment for animals having canine distemper by administering a composition comprising an attenuated canine measles virus a sub-vaccine virus level effective to alleviate symptoms canine distemper.
    Type: Application
    Filed: December 22, 2000
    Publication date: October 18, 2001
    Inventor: John McMichael
  • Patent number: 6303127
    Abstract: The invention presents methods for the treatment of symptoms associated with diseases states including cardiomyopathy, Parkinson's Disease and degenerative liver disease including cirrhosis comprising treatment with an effective amount of a composition comprising beta-amyloid, streptolysin O, and growth hormone.
    Type: Grant
    Filed: August 11, 1998
    Date of Patent: October 16, 2001
    Assignee: Milkhaus Laboratory, Inc.
    Inventors: John McMichael, Harry C. Gurney
  • Patent number: 6294171
    Abstract: The invention provides methods and compositions for treating the symptoms of disease states associated with the presence of a toxin or infectious agent having the step of administering an antibody specific for the toxin or infectious agent at a dosage of less than 0.1 mg per day.
    Type: Grant
    Filed: January 31, 2001
    Date of Patent: September 25, 2001
    Assignee: Milkhaus Laboratory, Inc.
    Inventor: John McMichael
  • Publication number: 20010018053
    Abstract: The invention provides methods and compositions for treating the symptoms of disease states associated with the presence of a toxin or infectious agent having the step of administering an antibody specific for the toxin or infectious agent at a dosage of less than 0.1 mg per day.
    Type: Application
    Filed: January 31, 2001
    Publication date: August 30, 2001
    Inventor: John McMichael
  • Patent number: 6267116
    Abstract: A method and system for use in treating a patient receiving any drug to optimize therapy and to prevent an adverse drug response. This system employs surrogate markers or indicators, including blood levels of drug, to determine the next required dose for a patient. Before surrogate markers are employed as a percent change in status, virtually any indicator can be used. Surrogate markers could include any measure the effectiveness of a drug's action. Given the effectiveness of the drug's action, relative to the surrogate markers, a change in drug dose is calculated by the system. Conversely, by employing this system, one could determine the expected result of a drug dose change on the surrogate markers.
    Type: Grant
    Filed: July 6, 1999
    Date of Patent: July 31, 2001
    Assignee: The RxFiles Corporation
    Inventor: John McMichael
  • Patent number: 6187309
    Abstract: The present invention provides a method for treating the symptoms of autism comprising the step of administering an effective amount of anti-rubeola antibody.
    Type: Grant
    Filed: February 29, 2000
    Date of Patent: February 13, 2001
    Assignee: Milkaus Laboratory, Inc.
    Inventors: John McMichael, Allan D. Lieberman
  • Patent number: 6174916
    Abstract: Methods and compositions are provided for alleviation of disease states involving plaque formation, such as are manifested in Alzheimer's Disease and other amyloid disorders, and arteriosclerotic disease. Methods for the treatment of herpes virus infections including chronic fatigue syndrome by administration of thimerosal are further provided by the invention.
    Type: Grant
    Filed: April 1, 1998
    Date of Patent: January 16, 2001
    Assignee: Milkhaus Laboratory, Ltd.
    Inventor: John McMichael
  • Patent number: 6156780
    Abstract: The present invention relates to a treatment for patients having fecal incontinence by administering a composition comprising histamine, serotonin or a combination thereof in an amount effective to alleviate symptoms of fecal incontinence.
    Type: Grant
    Filed: August 11, 1998
    Date of Patent: December 5, 2000
    Assignee: Milkhaus Laboratory, Inc.
    Inventor: John McMichael
  • Patent number: 6100244
    Abstract: Methods for treating symptoms of respiratory distress not associated with aberrant mucous accumulation in a patient, are presented. Methods comprise administering an effective amount of DNA to a subject in a manner so as not to effect gene transfer.
    Type: Grant
    Filed: November 3, 1999
    Date of Patent: August 8, 2000
    Assignee: Milkhaus Laboratory, Inc.
    Inventor: John McMichael
  • Patent number: 6096721
    Abstract: Methods for treating mucositis are presented. An effective amount of DNA is administered to a patient with mucositis sublingually in a manner that does not cause gene transfer but does cause a reduction in viscosity of mucous or sputum.
    Type: Grant
    Filed: March 10, 1998
    Date of Patent: August 1, 2000
    Assignee: Milkhaus Laboratory, Inc.
    Inventor: John McMichael
  • Patent number: 6020314
    Abstract: Methods are provided of treating the symptoms of neurological disorders including those selected from the group consisting of autism, multiple sclerosis and enuresis by administering to a patient diagnosed with the neurological disorder a composition containing an effective amount of secretin.
    Type: Grant
    Filed: August 11, 1998
    Date of Patent: February 1, 2000
    Assignee: Milkhaus Laboratory, Inc.
    Inventor: John McMichael
  • Patent number: 5955442
    Abstract: Methods for treating respiratory disease, including cystic fibrosis, emphysema, bronchitis, and sinusitis are presented. Methods comprise administering to a patient an effective amount of DNA in a manner so as not to be effect gene transfer and expression.
    Type: Grant
    Filed: February 13, 1998
    Date of Patent: September 21, 1999
    Assignee: Milkhaus Laboratory, Inc.
    Inventor: John McMichael
  • Patent number: 5948768
    Abstract: Methods for treating symptoms of otitis media in a patient, are presented. Methods comprise administering an effective amount of DNA to a subject in a manner so as not to effect gene transfer.
    Type: Grant
    Filed: July 28, 1998
    Date of Patent: September 7, 1999
    Assignee: Milkhaus Laboratory
    Inventors: John McMichael, Michael Allen